Method for processing condensed pill for regaining sight

A processing method and technology of concentrated pills, which are applied in the medical field, can solve the problems of no effective treatment drugs and long course of disease, and achieve remarkable curative effect, simple administration, and improved eyesight

Active Publication Date: 2014-04-30
盛翔
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Third: suffering from iridocyclitis, the course of the disease is too long, especially the old iris synechia and most of the posterior synechia of the pupil, the use of strong mydriasis has been ineffective
Cataract, glaucoma and other eye diseases, currently there is no effective treatment drug in Chinese and Western medicine at home and abroad

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for processing condensed pill for regaining sight
  • Method for processing condensed pill for regaining sight

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0052] Such as figure 1 , figure 2As shown, a 40-year-old man in Jingjiang City, Jiangsu Province, has suffered from ankylosing spondylitis for 20 years, accompanied by iridocyclitis for more than 10 years. He first suffered from iritis in his right eye, and later due to repeated attacks of the disease, his left eye also suffered from iritis. iritis. Before the onset of acute iritis, the uncorrected visual acuity of both eyes was 1.5. However, it took only a few days for the acute iridocyclitis to appear, resulting in sudden pain in the right eye within a few days, sudden loss of vision and blindness. In May 2008, it was jointly diagnosed by the Department of Ophthalmology of Jingjiang People's Hospital, Department of Ophthalmology of Jingjiang Hospital of Traditional Chinese Medicine, Department of Ophthalmology of Wuxi Second People's Hospital and other medical institutions: acute iridocyclitis of both eyes, concurrent cataract of the right eye, and secondary glaucoma. C...

Embodiment 2

[0055] Example 2, a 65-year-old woman from Jingjiang City, Jiangsu Province, suffered from senile binocular cataracts caused by high blood pressure in October 2009, with blurred vision in both eyes, vision of the left eye was 0.2, and vision of the right eye was 0.3; After 6 courses of treatment, the visual acuity of the left eye is 0.8 and that of the right eye is 1.0.

Embodiment 3

[0056] Example 3, a woman in Nantong City, Jiangsu Province, 35 years old, suffered from early cataract caused by iritis in November 2009, her vision was 0.5 in the left eye and 0.4 in the right eye; after taking Zangyan Fuming Concentrated Pills for 4 courses, her vision is now left 0.8 for the eye and 0.6 for the right eye.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method for processing a condensed pill for treating eye disease. Medicinal prescription of 3000 condensed pills comprises the following components of 10-15g of pearl powder from bred mussels, 15-20g of cloud notoginseng powder, 5-10g of fructus viticis, 8-10g of selfheal spike, 8-10g of angelica sinensis, 5-10g of ligusticum wallichii and the like. The product pill is prepared by the processes of decocting crude drugs, crushing raw materials, refining old honey and the like. The vision of a sufferer can be effectively improved; muscae volitantes and clumps ghosting of the affected eye caused by vitreous opacities can be removed; middle concurrency cataracts caused by lens opaque can be effectively reversed; bulbi hypertonia of the affected eye caused by secondary glaucoma can be reversely reduced to within a normal value of 10-21mmHg; and the pain of the sufferer during extraction eyeball by a western medicine surgery is removed. Therefore, the medical problem that difficult eye diseases cannot be solved by western medicine at present is overcome.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a method for processing concentrated pills for treating eye diseases. Background technique [0002] At present, in China, the treatment of iris adhesion, pupillary atresia, concurrent cataract caused by binocular iridocyclitis, and secondary neovascular glaucoma, or floaters and blurred vision caused by viral keratitis and vitreous opacity A series of difficult ophthalmic diseases such as blurred vision, sudden loss of vision, or senile cataracts caused by age have not been cured by specific drugs so far. Western medicine mainly uses hormones, antibiotics and anti-inflammatory symptomatic treatment, or surgery to lower intraocular pressure. In severe cases, it is necessary to remove the eyeball that is painful and swollen due to glaucomatous high intraocular pressure. Moreover, the recurrence rate of glaucoma after surgical treatment is as high as 20%-30%, and some patients need multiple...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/8969A61P27/12A61K35/64A61K35/56A61K35/583A61K35/618A61K35/644A61K35/646A61K35/648
Inventor 盛翔
Owner 盛翔
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap